Jake Mathon

Principal Analyst, Pharma Intelligence - Citeline Cardiometabolic, Infectious & Genitourinary Diseases. Views are mine.

[Jake Mathon @CitelineJakeM]

Not just a horse drug. 83 studies worldwide of ivermectin in COVID have started. 41 have completed - involving over 14K subjects. 18 studies have positive results vs. just 2 with negative results. Remainder are unknown or mixed/indeterminate.

[Jake Mathon @CitelineJakeM]

#FivePerfectMovies
OK, I'll play. Here goes...

The Shawshank Redemption
12 Angry Men
Goodfellas
The Great Escape
Cool Hand Luke

Honorable Mention:
The Ten Commandments
Good Will Hunting
The Hunt for Red October
Die Hard (Best villain ever; not a Christmas movie)

[Jake Mathon @CitelineJakeM]

If China's clinical trials/COVID-19 case ratio was actually anywhere near the average of US, Spain, Italy, UK, & France, their total cases would be much closer to 1.5 million - or 17X higher than reported. #coronavirus
@Citeline @Pharma_Intell

[Jake Mathon @CitelineJakeM]

These numbers are telling me something. Can you guess what it is? #coronavirus
@Citeline @Pharma_Intell

[Jake Mathon @CitelineJakeM]

Quick update on #COVID19 clinical trials. 193 running or planned for near future. That's 50 new studies added in just SIX days. Roughly 30K patients for treatment & 20K for prevention. Almost all in China. But it's just like the flu, right? #coronavirus @Citeline @Pharma_Intell

[Jake Mathon @CitelineJakeM]

FDA OK's New Cholesterol Drug https://t.co/NZBopoboL3

[STAT @statnews]

More than 120 clinical trials testing treatments for #coronavirus disease have either gotten underway or are planned in coming weeks, according to new data. https://t.co/EVGqohInIX

[Jake Mathon @CitelineJakeM]

#COVID19 143 clinical trials involving nearly 23,000 sick patients for treatment and 20,000 healthy subjects for prevention. #coronavirus
@Citeline @Pharma_Intell

[Gabrielle Gessner @CitelineGGess]

#COVID19 response is fast and furious - can we catch up in time? #coronavirus
@Citeline @Pharma_Intell

[Jake Mathon @CitelineJakeM]

How big is #COVID19 compared to SARS? 143 clinical trials running or planned within two months vs. 18 trials over 15 years. Massive response. #coronavirus
@Citeline @Pharma_Intell

[Jake Mathon @CitelineJakeM]

EB-5 development fraud involving AnC Bio results in federal indictments. https://t.co/GqbR1NZQrG

[Jake Mathon @CitelineJakeM]

Gout drug could help treat heart failure https://t.co/b2kUN4JYjE via @mnt

[Jake Mathon @CitelineJakeM]

Aspirin just as good as Xarelto for preventing clots after hip, knee surgery https://t.co/hJsyUcZ0GV

[Jake Mathon @CitelineJakeM]

Israeli biotech company successfully grows bones in lab https://t.co/6SlsPd8uvL

[Jake Mathon @CitelineJakeM]

@datamonitor_JA Average treatment duration for Phase II industry sponsored NAFLD trials is 7.3 months. Median duration is 4 months.

[Jake Mathon @CitelineJakeM]

FDA Establishes Precedent by Approving AI-Powered Stroke Triage Software | Healthcare Analytics News https://t.co/qjQPPsKk0C via @HCA_News

[Jake Mathon @CitelineJakeM]

Estimation of clinical trial success rates and related parameters | Biostatistics | Oxford Academic https://t.co/sfqRZXqNd3

[World Thrombosis Day @thrombosisday]

Every patient admitted to the hospital should be assessed for his or her risk of developing a #VTE. Why? Because up to 60% of all #VTEs are associated with a hospital stay. Know your right. Ask! #KnowThrombosis #KeepLifeFlowing

[John LaMattina @John_LaMattina]

How Much Profit Should Novartis Earn By Curing A Childhood Leukemia? via @forbes https://t.co/kFERKJ42P7

[Jake Mathon @CitelineJakeM]

Flu relief is coming as successors to aging Tamiflu near market https://t.co/rviKNiplu5 via @seattletimes